文献速递肺外科心外重症与机械循环支持

肺复合分配评分(CAS)实施对体外膜肺氧合(ECMO)桥接肺移植的影响

Effects of the Lung Composite Allocation Score Change on Extracorporeal Membrane Oxygenation (ECMO) Bridge to Transplant.
PubMed 文献 · Ann Thorac Surg · 2025-11-08

该UNOS回顾性研究纳入2022年1月至2024年6月6406例成人肺移植受者,比较CAS实施前后ECMO桥接移植(BTT)的使用与结局。CAS后ECMO BTT比例下降(5.8% vs 7.8%,P=.002),但ECMO BTT患者等待名单时间和ECMO至移植时间显著缩短,术后再插管率升高(22.3% vs 12.8%,P=.013),其他结局相似。

要点

  • CAS实施后ECMO BTT移植比例下降(5.8% vs 7.8%,P=.002),ECMO患者登记数减少。
  • ECMO BTT患者ECMO至移植中位时间缩短(7 vs 19.5天,P<.001),总等待名单时间缩短(8.5 vs 17.0天,P<.001)。
  • CAS后ECMO BTT患者术后再插管率升高(22.3% vs 12.8%,P=.013),匹配后仍存在。

核心结论

  • CAS实施后ECMO BTT登记和移植均减少,但接受移植者等待名单时间和ECMO支持时间缩短,长期结局待明确。

研究设计与样本

  • 基于UNOS数据库的回顾性研究,纳入2022年1月1日至2024年6月1日成人肺移植受者共6406例,排除多器官移植、既往肺移植和失访者。
  • 比较CAS实施前与实施后ECMO BTT使用情况及ECMO支持时间,并对ECMO BTT亚组进行倾向性匹配分析评估术后结局。

主要发现

  • CAS后ECMO BTT比例下降(5.8% vs 7.8%,P=.002),静脉-动脉和静脉-静脉ECMO病例均减少(P=.011)。
  • CAS后ECMO患者登记比例降低(8.3% vs 10.3%,P=.005),但已登记ECMO患者的移植率相似(59.3% vs 63.3%,P=.242)。
  • ECMO BTT亚组中,CAS后受者年龄更大(中位55 vs 50岁,P=.001),既往吸烟者更多(44.4% vs 30.5%,P=.004),COVID-19诊断更少(3.1% vs 32.6%,P<.001)。
  • ECMO类型无差异(P=.635);ECMO至移植中位时间缩短(7 vs 19.5天,P<.001),总等待名单时间缩短(中位8.5 vs 17.0天,P<.001)。
  • 术后再插管率CAS后更高(22.3% vs 12.8%,P=.013),匹配后仍显著;72小时ECMO、气道裂开、住院时间和30天死亡率相似。

临床怎么用

  • CAS实施后ECMO BTT患者可更快获得供肺、缩短ECMO支持时间,但需关注术后再插管风险升高。

局限性

  • 为回顾性UNOS数据库研究,长期结局尚未确定。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: In March 2023, lung allocation changed to the composite allocation score (CAS), aiming to improve access for sicker patients. This study examines CAS effects on patients bridged to transplant (BTT) with extracorporeal membrane oxygenation (ECMO). METHODS: This United Network for Organ Sharing (UNOS) study included adult lung transplants from January 1, 2022, to June 1, 2024, excluding multiorgan, prior lung transplants, and loss to follow-up. We compared ECMO BTT use and time on ECMO pre-CAS vs post-CAS. Propensity-matched analysis assessed postoperative outcomes in the ECMO BTT subgroup. RESULTS: Among 6406 recipients, ECMO BTT rates decreased post-CAS (5.8% vs 7.8%, P = .002), with fewer venoarterial and venovenous cases (P = .011). Fewer ECMO patients were listed post-CAS (8.3% vs 10.3%, P = .005), but transplant rates for listed ECMO patients were similar (59.3% vs 63.3%, P = .242). In the ECMO BTT subgroup, post-CAS recipients were older (median age 55 vs 50 years, P = .001), previous smokers (44.4% vs 30.5%, P = .004), with fewer coronavirus disease diagnoses (3.1% vs 32.6%, P < .001). ECMO type did not differ (P = .635). Time from ECMO to transplant significantly decreased (median 7 vs 19.5 days, P < .001), as did total waiting list time (median 8.5 vs 17.0 days, P < .001). Postoperatively, reintubation was higher for ECMO BTT patients post-CAS (22.3% vs 12.8%, P = .013), which persisted after matching. Other outcomes (ECMO at 72 hours, airway dehiscence, length of stay, and 30-day mortality) were similar. CONCLUSIONS: Under CAS, ECMO BTT listings and transplants both decreased. However, those who do undergo transplantation receive lungs with shorter waiting list times and time on ECMO. Long-term outcomes remain to be determined.

来源:Ann Thorac Surg,查看原文。版权归原作者所有。

引用

  1. Li SS, Makarem A, Kreso A, et al. Effects of the Lung Composite Allocation Score Change on Extracorporeal Membrane Oxygenation (ECMO) Bridge to Transplant. Ann Thorac Surg. 2025. PMID: 41207422. doi:10.1016/j.athoracsur.2025.10.026

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。